vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and GEN Restaurant Group, Inc. (GENK). Click either name above to swap in a different company.
GEN Restaurant Group, Inc. is the larger business by last-quarter revenue ($49.7M vs $44.9M, roughly 1.1× AbCellera Biologics Inc.). GEN Restaurant Group, Inc. runs the higher net margin — -3.8% vs -19.9%, a 16.1% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -9.0%). GEN Restaurant Group, Inc. produced more free cash flow last quarter ($-5.6M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -1.0%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Gen Korean BBQ is an American chain of all-you-can-eat Korean barbecue restaurants mainly concentrated around the Western U.S. It opened in 2011, and has since grown to 43 locations as of 2024.
ABCL vs GENK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $49.7M |
| Net Profit | $-8.9M | $-1.9M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | -24.5% |
| Net Margin | -19.9% | -3.8% |
| Revenue YoY | 788.4% | -9.0% |
| Net Profit YoY | 73.9% | -821.4% |
| EPS (diluted) | $-0.03 | $-0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $49.7M | ||
| Q3 25 | $9.0M | $50.4M | ||
| Q2 25 | $17.1M | $55.0M | ||
| Q1 25 | $4.2M | $57.3M | ||
| Q4 24 | $5.0M | $54.7M | ||
| Q3 24 | $6.5M | $49.1M | ||
| Q2 24 | $7.3M | $53.9M | ||
| Q1 24 | $10.0M | $50.8M |
| Q4 25 | $-8.9M | $-1.9M | ||
| Q3 25 | $-57.1M | $-566.0K | ||
| Q2 25 | $-34.7M | $-261.0K | ||
| Q1 25 | $-45.6M | $-301.0K | ||
| Q4 24 | — | $-206.0K | ||
| Q3 24 | $-51.1M | $25.0K | ||
| Q2 24 | $-36.9M | $277.0K | ||
| Q1 24 | $-40.6M | $496.0K |
| Q4 25 | -63.7% | -24.5% | ||
| Q3 25 | -851.8% | -7.4% | ||
| Q2 25 | -290.2% | -3.4% | ||
| Q1 25 | -1479.6% | -3.8% | ||
| Q4 24 | — | -2.4% | ||
| Q3 24 | -1439.4% | 0.2% | ||
| Q2 24 | -1276.2% | 3.0% | ||
| Q1 24 | -551.5% | 0.2% |
| Q4 25 | -19.9% | -3.8% | ||
| Q3 25 | -637.8% | -1.1% | ||
| Q2 25 | -203.3% | -0.5% | ||
| Q1 25 | -1077.2% | -0.5% | ||
| Q4 24 | — | -0.4% | ||
| Q3 24 | -785.4% | 0.1% | ||
| Q2 24 | -504.3% | 0.5% | ||
| Q1 24 | -408.0% | 1.0% |
| Q4 25 | $-0.03 | $-0.37 | ||
| Q3 25 | $-0.19 | $-0.11 | ||
| Q2 25 | $-0.12 | $-0.05 | ||
| Q1 25 | $-0.15 | $-0.06 | ||
| Q4 24 | — | $-0.05 | ||
| Q3 24 | $-0.17 | $0.01 | ||
| Q2 24 | $-0.13 | $0.06 | ||
| Q1 24 | $-0.14 | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $2.8M |
| Total DebtLower is stronger | — | $13.6M |
| Stockholders' EquityBook value | $966.9M | $26.5M |
| Total Assets | $1.4B | $259.9M |
| Debt / EquityLower = less leverage | — | 0.51× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $2.8M | ||
| Q3 25 | $83.2M | $4.8M | ||
| Q2 25 | $92.4M | $9.6M | ||
| Q1 25 | $159.3M | $15.4M | ||
| Q4 24 | $156.3M | $23.7M | ||
| Q3 24 | $126.6M | $22.1M | ||
| Q2 24 | $148.3M | $29.2M | ||
| Q1 24 | $123.6M | $28.1M |
| Q4 25 | — | $13.6M | ||
| Q3 25 | — | $10.8M | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | — | $6.5M | ||
| Q4 24 | — | $6.9M | ||
| Q3 24 | — | $7.2M | ||
| Q2 24 | — | $7.6M | ||
| Q1 24 | — | $7.7M |
| Q4 25 | $966.9M | $26.5M | ||
| Q3 25 | $964.0M | $38.1M | ||
| Q2 25 | $1.0B | $41.0M | ||
| Q1 25 | $1.0B | $42.8M | ||
| Q4 24 | $1.1B | $44.1M | ||
| Q3 24 | $1.1B | $46.5M | ||
| Q2 24 | $1.1B | $45.9M | ||
| Q1 24 | $1.1B | $40.4M |
| Q4 25 | $1.4B | $259.9M | ||
| Q3 25 | $1.4B | $245.5M | ||
| Q2 25 | $1.4B | $246.3M | ||
| Q1 25 | $1.3B | $232.4M | ||
| Q4 24 | $1.4B | $240.4M | ||
| Q3 24 | $1.4B | $225.7M | ||
| Q2 24 | $1.4B | $218.8M | ||
| Q1 24 | $1.5B | $214.5M |
| Q4 25 | — | 0.51× | ||
| Q3 25 | — | 0.28× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | 0.16× | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.17× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $-426.0K |
| Free Cash FlowOCF − Capex | $-44.6M | $-5.6M |
| FCF MarginFCF / Revenue | -99.4% | -11.3% |
| Capex IntensityCapex / Revenue | 21.9% | 10.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $-24.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $-426.0K | ||
| Q3 25 | $-52.6M | $-1.6M | ||
| Q2 25 | $-32.4M | $3.3M | ||
| Q1 25 | $-11.6M | $2.2M | ||
| Q4 24 | $-108.6M | $7.3M | ||
| Q3 24 | $-28.9M | $1.4M | ||
| Q2 24 | $-30.0M | $5.6M | ||
| Q1 24 | $-41.7M | $3.5M |
| Q4 25 | $-44.6M | $-5.6M | ||
| Q3 25 | $-61.5M | $-7.7M | ||
| Q2 25 | $-45.8M | $-6.3M | ||
| Q1 25 | $-22.2M | $-4.7M | ||
| Q4 24 | $-187.0M | $165.0K | ||
| Q3 24 | $-47.4M | $-6.8M | ||
| Q2 24 | $-50.1M | $1.2M | ||
| Q1 24 | $-65.8M | $-586.0K |
| Q4 25 | -99.4% | -11.3% | ||
| Q3 25 | -687.0% | -15.3% | ||
| Q2 25 | -267.9% | -11.5% | ||
| Q1 25 | -524.0% | -8.2% | ||
| Q4 24 | -3702.8% | 0.3% | ||
| Q3 24 | -728.4% | -13.9% | ||
| Q2 24 | -683.8% | 2.3% | ||
| Q1 24 | -661.5% | -1.2% |
| Q4 25 | 21.9% | 10.5% | ||
| Q3 25 | 99.7% | 12.0% | ||
| Q2 25 | 78.2% | 17.5% | ||
| Q1 25 | 251.1% | 11.9% | ||
| Q4 24 | 1552.7% | 13.1% | ||
| Q3 24 | 284.6% | 16.9% | ||
| Q2 24 | 274.6% | 8.0% | ||
| Q1 24 | 242.5% | 8.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 57.96× | ||
| Q2 24 | — | 20.06× | ||
| Q1 24 | — | 7.08× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
